Myasthenia And HIV Infection: An Unusual Combination, One Case Report In Abidjan, Ivory Coast
Keywords:
Myasthenia gravis, HIV, Immunosuppressive therapy, Antiretroviral treatment, Ivory CoastAbstract
Introduction: The co-occurrence of autoimmune myasthenia gravis and HIV infection is poorly documented. Existing cases of combination myasthenia gravis and HIV are often associated with immune reconstitution inflammatory syndrome (IRIS), whereas the onset of myasthenia gravis prior to HIV diagnosis is exceptional. Observation: We report the case of a 43-year-old woman with seronegative generalized myasthenia gravis since 2002, 23 years before presentation, diagnosed with HIV-1 infection in 2009, 16 years before presentation. She was virologically stable on triple antiretroviral therapy (CD4 = 993/mm³, undetectable viral load). Electroneuromyography showed a 25% decremental response on repetitive nerve stimulation. Anti-AChR antibodies were negative; MuSK and LRP4 were not tested. During a myasthenic crisis with respiratory distress and muscarinic features, pyridostigmine was stopped and resuscitation measures were undertaken. Subsequent corticosteroid and azathioprine therapy led to marked improvement (Garches score 55 → 85 after 8 months). Conclusion: This rare case of myasthenia preceding HIV diagnosis illustrates an association independent of IRIS. It suggests that immunosuppressive therapy can be used safely in well-controlled HIV infection under close virological and immunological monitoring within a multidisciplinary framework.
Downloads
References
Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA. The epidemiology of myasthenia gravis. J Med Life. 2021;14(1):7-16. doi:10.25122/jml-2020-0145.
Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023-36. doi:10.1016/S1474-4422(15)00141-0.
Heckmann JM, Marais S. Management issues in myasthenia gravis patients living with HIV: a case series and literature review. Front Neurol. 2020; 11:775. doi:10.3389/fneur.2020.00775.
Sherpa M, Metai RK, Kumar V, Hirachan T, Ahmed KU, Atkinson SJ. Comorbid human immunodeficiency virus (HIV) and muscle-specific kinase (MuSK) myasthenia gravis: a case report and literature review. Am J Case Rep. 2017;18:427-30. doi:10.12659/AJCR.902831.
Ragunathan K, Pathak B, Dahal K. MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient. J Neurol. 2015;262(3):777-8. doi:10.1007/s00415-014-7582-5.
Choudhary A, Kumar N, Gupta S, Anand R, Verma R, Sharma P, et al. Myasthenia gravis in HIV-infected patients: report of two cases and review of the literature. J Clin Neuromuscul Dis. 2014;15(4):159-64. doi:10.1097/CND.0000000000000041.
O’Connor KC, Sriram S, Vincent A. Autoimmune neuromuscular disorders in HIV-positive patients: emerging evidence. Curr Opin Neurol. 2019;32(5):775-85. doi:10.1097/WCO.0000000000000740.
Wirtz PW. Dysphagia and respiratory failure in an HIV patient: MuSK myasthenia gravis. Acta Neurol Belg. 2020;120(6):1483-4. doi:10.1007/s13760-020-01461-9.
Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJ. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30. doi:10.1038/s41572-019-0085-1.
Farrugia ME, Goodfellow JA. A practical approach to managing patients with myasthenia gravis: opinions and a review of the literature. Front Neurol. 2020;11:604. doi:10.3389/fneur.2020.00604.
Downloads
Published
License
Copyright (c) 2026 East African Journal of Neurological Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.